Skip to main content
Published locations for Second-line vs later-line zanubrutinib improves survival in relapsed or refractory MCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Second-line vs later-line zanubrutinib improves survival in relapsed or refractory MCL
User login
Username
Password
Reset your password
/content/second-line-vs-later-line-zanubrutinib-improves-survival-relapsed-or-refractory-mcl
/b-cell-lymphoma-icymi/article/266055/b-cell-lymphoma/second-line-vs-later-line-zanubrutinib-improves